PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
42 hedge funds and large institutions have $328M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
6
Reduced
8
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$41.3M |
| 2 |
BlackRock
New York
|
$5.46M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
$2.95M |
| 4 |
Bank of New York Mellon
New York
|
$2.58M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.88M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MWNA
51
Marshall Wace North America
New York
| – | -$520K | -39,414 | Closed |
|
52
Goldman Sachs
New York
| – | -$497K | -37,642 | Closed |
|
|
CSS
53
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$230K | -17,425 | Closed |
|
54
SG Americas Securities
New York
| – | -$194K | -14,706 | Closed |
|
|
PHK
55
Point72 Hong Kong
Hong Kong
| – | -$106K | -8,000 | Closed |
|
56
Blackstone Inc
New York
| – | -$66K | -5,000 | Closed |
|
|
TRCT
57
Tower Research Capital (TRC)
New York
| – | -$8K | -614 | Closed |
|
|
FIA
58
FNY Investment Advisers
New York
| – | -$7K | -600 | Closed |
|
|
CCA
59
Catalyst Capital Advisors
Huntington,
New York
| – | -$7K | -500 | Closed |
|